Xlear Nasal Decongestant
NDC 27017-018, Nasal Spray, liquid, from Xlear Inc..
- Product NDC
- 27017-018
- Status
- Listed
- Labeler
- Xlear Inc.
- Dosage form
- LIQUID
- Route
- NASAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M012
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/27017-018 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OXYMETAZOLINE HYDROCHLORIDE.0005 g/g
Pharmacologic classes
Imidazolines [CS]; Increased Sympathetic Activity [PE]; Vasoconstriction [PE]; Vasoconstrictor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 27017-018-01 | 27017001801 | 1 g in 1 BOTTLE, SPRAY (27017-018-01) |
Linked data
RxNorm, label and prices
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 27017-018 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/27017-018 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 27017-018. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.